The Infixion Bioscience mission is to develop and deliver FDA approved treatments to people living with Neurofibromatosis (NF1). The Infixion team of NF1 parents and drug discovery experts have built a lab, a dream-team of advisors & collaborators, and demonstrated proof-of-concept for its drug discovery path. Having relied almost exclusively on grant funding, Infixion is now seeking private funding to execute the next phase of its drug discovery effort. Although an orphan disease, NF1 affects 125K Americans and 2.5M worldwide, thus having a large and demonstrated market potential. Please reach out anytime to learn more.